HRMY
Harmony
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
HRMY Profile
Harmony Biosciences Holdings, Inc.
A pharmaceutical company focused on therapies for rare neurological diseases
Pharmaceutical
07/25/2017
08/19/2020
NASDAQ Stock Exchange
268
12-31
Common stock
630 W. Germantown Pike, Suite 215, Plymouth Meeting, PA 19462
--
Harmony Biosciences Holdings, Inc., founded on July 25, 2017, is a commercial-stage pharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with rare neurological diseases with unmet medical needs. The company's product, WAKIX (pitolisant), is a first-in-class molecule with a novel mechanism of action, or MOA, specifically designed to enhance histamine signaling in the brain by binding to H3 receptors.